Previous Article | Next Article ![]()
Infection and Immunity, December 2000, p. 6883-6890, Vol. 68, No. 12
Department of Immunology, Osaka Medical
Center for Cancer and Cardiovascular Diseases, Higashinari-ku,
Osaka 537-8511,1 Institute of
Immunological Science, Hokkaido University, Kita-ku, Sapporo
060,4 Department of Host Defense,
Research Institute for Microbial Diseases, Osaka University, Osaka
565,3 and Organization for
Pharmaceutical Safety and Research, Tokyo
100-0013,2 Japan
Received 3 August 2000/Accepted 15 September 2000
The constituents of mycobacteria are an effective immune adjuvant,
as observed with complete Freund's adjuvant. In this study, we
demonstrated that the cell wall skeleton of Mycobacterium
bovis bacillus Calmette-Guérin (BCG-CWS), a purified
noninfectious material consisting of peptidoglycan, arabinogalactan,
and mycolic acids, induces maturation of human dendritic cells (DC).
Surface expression of CD40, CD80, CD83, and CD86 was increased by
BCG-CWS on human immature DC, and the effect was similar to those of
interleukin-1
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Maturation of Human Dendritic Cells by Cell Wall
Skeleton of Mycobacterium bovis Bacillus
Calmette-Guérin: Involvement of Toll-Like Receptors

(IL-1
), tumor necrosis factor alpha (TNF-
),
heat-killed BCG, and viable BCG. BCG-CWS induced the secretion of
TNF-
, IL-6, and IL-12 p40. CD83 expression was increased by a
soluble factor secreted from BCG-CWS-treated DC and was completely
inhibited by monoclonal antibodies against TNF-
. BCG-CWS-treated DC
stimulated extensive allogeneic mixed lymphocyte reactions. The level
of TNF-
secreted through BCG-CWS was partially suppressed in murine macrophages with no Toll-like receptor 2 (TLR 2) or TLR4 and was completely lost in TLR2 and TLR4 double-deficient macrophages. These
results suggest that the BCG-CWS induces TNF-
secretion from DC via
TLR2 and TLR4 and that the secreted TNF-
induces the maturation of
DC per se.
*
Corresponding author. Mailing address: Department of
Immunology, Osaka Medical Center for Cancer and Cardiovascular
Diseases, Higashinari-ku, Osaka 537 Japan. Phone and fax: 81 6 6973 1209. E-mail: tseya{at}mail.mc.pref.osaka.jp.
Present address: Hakodate National College of Technology, Hakodate
042-8501, Japan.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|